NCT01372800Recruiting
Serum Adiponectin in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases
Serum Adiponectin Concentration, Activity and Isoforms in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases
Source: ClinicalTrials.gov · Last updated 7 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Adiponectin (Ad) is an abundant protein in human body, and reports have shown that it act as a novel risk factor for brain and heart ischemia injury. This 5 years follow-up study will focus on serum adiponectin concentration, activity and isoforms in Chinese population and its correlation to these diseases.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 30000 (estimated)
- First submitted
- 10 Jun 2011
- Start date
- 1 May 2011
- Primary completion date
- 1 Oct 2026
- Lead sponsor
- Xijing Hospital
- Diseases
- Coronary artery disease, Stroke
- NCT number
- NCT01372800
What you commit to
- Study type: Observational
- Planned participants: 30000
- From 1 May 2011 to the primary completion date, 1 Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Death caused other than cardiovascular and cerebralvascular diseases till the study ends
Lab values
- Active hepatic disease or hepatic dysfunction, or AST/ALT \> 1.5UNL
- Severe renal dysfunction(Scr \> 3 mg/dl or 264μmol/L)
- Patients with any condition which, in the investigator's judgment, might increase the risk to the subject for any adverse event or abnormal laboratory finding
Other
- Floating Population
- Pregnancy, lactation, or child bearing women
- Tumor
Who the study is looking for
- available for 5 years of follow-up study
Age in the registry: 18 years to 85 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Xijing hospital Coordinator of this site? Confirm its status | Xi'an | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.